Diskussionsleiter: H.-D. Düngen (Berlin), R. Wachter (Göttingen)
| (P1606) | Nicht-kardiale Probleme betreffende Versorgungsbedürfnisse herzinsuffizienter Patienten |
| S. Kreissl, S. Störk, G. Gelbrich, M. Hanke, H. Faller, G. Ertl, C. E. Angermann für die INH KNHI (Würzburg, Leipzig) | |
| (P1607) | Multi Compartment Body Composition Analysis in Chronic Heart Failure Air Displacement Plethysmography, Body Impedance Analysis, Dual-X-Ray-Absorptiometry, and 3D-White Light Scan Analysis |
| T. D. Trippel, A. Stahn, J. Lenk, S. von Haehling, W. Döhner, M. Osterland, E. Tahirovic, S. Inkrot, V. Tscholl, D. Obradovic, W. Haverkamp, H.-C. Gunga, H.-D. Düngen (Berlin) | |
| (P1608) | Regulation of iron metabolism in congestive heart failure without anemia |
| M. Fritzenwanger, C. Jung, M. Franz, H.-R. Figulla (Jena) | |
| (P1609) | Künstliche Neuronale Netze in der Analyse konsekutiver Daten des Telemonitoring bei chronischer Herzinsuffizienz |
| T. Heinze, A. Polze, M. von Löwis, C. Sprenger, M. Oeff (Potsdam, Brandenburg) | |
| (P1610) | First results of the Reitan Catheter Pump heart failure efficacy study |
| M. Ferrari, T. R. Keeble, E. J. Smith, C. Jung, R. Hullin, O. Reitan, F. Schersten, H.-R. Figulla, M. Rothman (Jena; London, UK; Lausanne, CH; Lund, SE) | |
| (P1611) | A risk factor-based porcine model of early heart failure with preserved ejection fraction. |
| M. Schwarzl, S. Seiler, N. Hamdani, W. Linke, P. Steendijk, B. Pieske, H. Post (Graz, AT; Bochum; Leiden, NL) | |
| (P1612) | GDF-15 levels improve reclassification for the diagnosis of diastolic heart failure in morbid obesity |
| M. Fischer, C. Strack, E. Rousseva, J. Bruxmeier, F. Wagner, G. Schmitz, G. Riegger, A. Bäßler (Regensburg) | |
| (P1613) | Tissue inhibitor of metalloproteinases-4 in patients with heart failure: Evidence of increased myocardial collagen turnover linked to diastolic dysfunction |
| W. Nickl, F. Kramer, M. Coll Barroso, T. Krahn, R. Füth, M. Lankisch, J. Gülker, R.-M. Klein, W. Dinh, M. Seyfarth (Wuppertal, Düsseldorf) | |
| (P1614) | Associations of methylarginines and homoarginine with diastolic dysfunction in patients at cardiovascular risk with preserved left ventricular ejection fraction |
| F. Edelmann, S. Pilz, A. Meinitzer, G. Gelbrich, H.-D. Düngen, A. Tomaschitz, A. Duvinage, B. Pieske, R. Wachter (Göttingen, Leipzig, Berlin; Graz, AT) | |
| (P1615) | Cyclic GMP Enhancing Therapy Promotes Titin Phosphorylation and Corrects High Cardiomyocyte Passive Stiffness in Diastolic Heart Failure |
| N. Hamdani, K. Bishu, J. van der Velden, G. Stienen, M. M. Redfield, W. Linke (Bochum; Rochester, US; Amsterdam, NL) | |
| (P1616) | Kardiales miRNA-Expressionsprofil bei Angiotensin-vermittelter diastolischer Herzinsuffizienz (DHF) |
| M. Willmer, H. M. Nef, S. Szardien, J. Hoffmann, D. Kraft, S. Voss, C. Troidl, C. Liebetrau, U. Fischer-Rasokat, K. Troidl, A. Elsässer, C. W. Hamm, H. Möllmann (Bad Nauheim, Oldenburg) |